Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Archana Moola"'
Autor:
Moris Sangineto, Martina Ciarnelli, Tommaso Cassano, Antonio Radesco, Archana Moola, Vidyasagar Naik Bukke, Antonino Romano, Rosanna Villani, Hina Kanwal, Nazzareno Capitanio, Loren Duda, Carlo Avolio, Gaetano Serviddio
Publikováno v:
Redox Biology, Vol 66, Iss , Pp 102846- (2023)
Microglia activation drives the pro-inflammatory activity in the early stages of Alzheimer's disease (AD). However, the mechanistic basis is elusive, and the hypothesis of targeting microglia to prevent AD onset is little explored. Here, we demonstra
Externí odkaz:
https://doaj.org/article/7a9317a9321844d280c6509e9a4ec4f2
Autor:
Moris Sangineto, Christoph Grander, Felix Grabherr, Lisa Mayr, Barbara Enrich, Julian Schwärzler, Marcello Dallio, Vidyasagar Naik Bukke, Archana Moola, Antonio Moschetta, Timon E. Adolph, Carlo Sabbà, Gaetano Serviddio, Herbert Tilg
Publikováno v:
Gut Microbes, Vol 14, Iss 1 (2022)
Alcohol-related liver disease (ALD) is a major cause of liver disease and represents a global burden, as treatment options are scarce. Whereas 90% of ethanol abusers develop alcoholic fatty liver disease (AFLD), only a minority evolves to steatohepat
Externí odkaz:
https://doaj.org/article/0ddb120444a241bca471377e37a98eb7
Autor:
Francesco Bellanti, Vidyasagar Naik Bukke, Archana Moola, Rosanna Villani, Caterina Scuderi, Luca Steardo, Gianmauro Palombelli, Rossella Canese, Sarah Beggiato, Mario Altamura, Gianluigi Vendemiale, Gaetano Serviddio, Tommaso Cassano
Publikováno v:
Frontiers in Aging Neuroscience, Vol 14 (2022)
The therapeutic potential of ultramicronized palmitoylethanolamide (um-PEA) was investigated in young (6-month-old) and adult (12-month-old) 3 × Tg-AD mice, which received um-PEA for 3 months via a subcutaneous delivery system. Mitochondrial bioener
Externí odkaz:
https://doaj.org/article/eb4fc34b055b4d509b299e586c485c12
Autor:
Vidyasagar Naik Bukke, Archana Moola, Gaetano Serviddio, Gianluigi Vendemiale, Francesco Bellanti
Publikováno v:
World Journal of Gastroenterology. 28:6909-6921
Autor:
Rosanna Villani, Moris Sangineto, Paola Pontrelli, Francesco Bellanti, Vidyasagar N. Bukke, Archana Moola, Loreto Gesualdo, Gianluigi Vendemiale, Giuseppe Grandaliano, Giovanni Stallone, Gaetano Serviddio
Publikováno v:
The FASEB Journal. 36
Hepatitis C virus (HCV) adopts several immune evasion mechanisms such as interfering with innate immunity or promoting T-cell exhaustion. However, the recent direct-antiviral agents (DAAs) rapidly eliminate the virus, and the repercussions in terms o
Autor:
Moris, Sangineto, Christoph, Grander, Felix, Grabherr, Lisa, Mayr, Barbara, Enrich, Julian, Schwärzler, Marcello, Dallio, Vidyasagar Naik, Bukke, Archana, Moola, Antonio, Moschetta, Timon E, Adolph, Carlo, Sabbà, Gaetano, Serviddio, Herbert, Tilg
Publikováno v:
Gut microbes. 14(1)
Alcohol-related liver disease (ALD) is a major cause of liver disease and represents a global burden, as treatment options are scarce. Whereas 90% of ethanol abusers develop alcoholic fatty liver disease (AFLD), only a minority evolves to steatohepat
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Archana Moola, Antonino Davide Romano, Gaetano Serviddio, Loren Duda, Francesco Bellanti, Rosanna Tamborra, Moris Sangineto, Vidyasagar Naik Bukke, Rosanna Villani
Publikováno v:
Nutrients, Vol 13, Iss 652, p 652 (2021)
Nutrients
Volume 13
Issue 2
Nutrients
Volume 13
Issue 2
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of liver disease globally, and represents a health care burden as treatment options are very scarce. The reason behind the NAFLD progression to non-alcoholic steatohepatitis (NASH) is not
Autor:
Rosanna Tamborra, Francesco Bellanti, Giorgia di Bello, Archana Moola, Francesco Cavallone, Naik Bukke Vidyasagar, Gaetano Serviddio, Rosanna Villani
Publikováno v:
Free radical biologymedicine. 156
Chronic hepatitis C therapy has completely changed in the last years due to the availability of direct-acting antivirals (DAAs). Removing the virus may be not enough since chronic infection deeply modifies immune system and cellular metabolism along
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.